Related Experiment Videos
Developmental changes of tetrahydrobiopterin in rat and human erythrocytes
K Azumagawa1, S Suzuki, M Mino
1Department of Pediatrics, Osaka Medical College, Takatsuki, Japan.
Insights
Tetrahydrobiopterin (BH4) levels in human erythrocytes remain stable with age. In contrast, Wistar rats exhibit developmental changes in BH4, suggesting other regulatory factors beyond enzyme activity or membrane permeability.
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- Tetrahydrobiopterin (BH4) is a crucial cofactor for several enzymes, including nitric oxide synthases and aromatic amino acid hydroxylases.
- Understanding BH4 homeostasis is vital for its therapeutic applications, particularly in conditions involving nitric oxide deficiency or altered amino acid metabolism.
Purpose of the Study:
- To investigate developmental changes in plasma and erythrocyte tetrahydrobiopterin (BH4) and related factors in humans and Wistar rats.
- To explore the relationship between BH4 levels, GTP cyclohydrolase activity, erythrocyte membrane permeability, and plasma phenylalanine.
- To identify potential species- and age-specific differences influencing BH4 regulation.
Main Methods:
- Measured plasma and erythrocyte BH4 levels, erythrocyte GTP cyclohydrolase activity, and plasma phenylalanine concentrations.
- Assessed erythrocyte membrane permeability to BH4 using in vitro experiments.
- Compared these parameters across different age groups in healthy human subjects and Wistar rats.
Main Results:
- In vitro studies confirmed passive transport of BH4 into erythrocytes.
- Human subjects showed consistent BH4 levels and related parameters across all age groups.
- Wistar rats displayed significant developmental changes in erythrocyte BH4, not directly explained by GTP cyclohydrolase, permeability, or phenylalanine levels.
Conclusions:
- BH4 homeostasis in Wistar rats is influenced by factors beyond those measured, possibly including BH4-binding capacity.
- Observed species and age differences in erythrocyte BH4 characteristics may impact the pharmacological use and efficacy of BH4 therapies.
- Further research is needed to elucidate the complex regulatory mechanisms of BH4 homeostasis.
Abstract:
In the present study, we investigated the developmental changes of (1) plasma and erythrocyte tetrahydrobiopterin (BH4); (2) erythrocyte GTP cyclohydrolase (the rate-limiting enzyme of BH4 biosynthesis); (3) the permeability of erythrocyte membrane to BH4; and (4) plasma phenylalanine, both in healthy human subjects and Wistar rats. In vitro experiments demonstrated passive transport of BH4 into erythrocytes. In humans, BH4 levels as well as the other parameters were fairly consistent across all age groups. In contrast, Wistar rats showed significant developmental changes in erythrocyte BH4, which were not simply correlated to either GTP cyclohydrolase, permeability to BH4 or plasma phenylalanine levels. This may suggest the existence of other factors regulating the homeostasis of BH4, such as BH4-binding capacity in plasma and/or erythrocytes. These species/age differences in erythrocyte characteristics may influence the pharmacological behavior and clinical efficacy of BH4 in humans and experimental animals.